Provider Barriers in Uptake of Biosimilars: Case Study on Fi

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.

Related Keywords

Delaware , United States , Cambridge , Cambridgeshire , United Kingdom , America , Americans , American , Van Nuys , Jessica Chang , Robert Wood Johnson Foundation , National Healthcare Quality , Services Administration , University Of Minnesota College Pharmacy , University Of Minnesota Carlson School Management , American Cancer Society , United Health Foundation , Us Census Bureau , Agency For Healthcare Research , University Of Minnesota Medical School , National Comprehensive Cancer Network , American Society Of Clinical Oncology , Health Aff Millwood , University Of Minnesota , National Institute For Health Care Management , National Bureau Of Economic Research , American Hospital Association Annual , Health Resources , University Of Minnesota School Public Health , American Hospital Association , Optumlabs Data Warehouse , American Hospital Association Annual Survey , Biologics License Application , Medicare Advantage , Optumlabs Visiting Fellow , Eden Prairie , Minnesota School , Public Health , National Bureau , Economic Research , Minnesota Carlson School , Mayo Clinic , Minnesota College , Minnesota Medical School , Koya Medical , Healthcare Research , National Institute , Health Care Management , National Institutes , Health Aff , Healthcare Quality , Disparities Report , Practice Guidelines , Clinical Oncology , Filgrastim , Biosimilar , Rural ,